Malaysia will be one of the first countries in Southeast Asia to conduct the Covid-19 seroprevalence (blood sampling) study, which among others, is to determine the level of Covid-19 infection comprehensively.

Health deputy director-general (Research and Technical Support) Dr Hishamshah Mohd Ibrahim said it is one of the study scopes under the National Health and Morbidity Survey (NHMS) this year.

"The findings of the seroprevalence study can...